Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$884M |
| 2 |
JD.com
JD
|
$784M |
| 3 |
Dollar General
DG
|
$667M |
| 4 |
Monster Beverage
MNST
|
$324M |
| 5 |
Starbucks
SBUX
|
$249M |
Top Sells
| 1 |
Union Pacific
UNP
|
$611M |
| 2 |
Mondelez International
MDLZ
|
$554M |
| 3 |
Alibaba
BABA
|
$438M |
| 4 |
CELG
Celgene Corp
CELG
|
$408M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
$362M |
Sector Composition
| 1 | Healthcare | 21.02% |
| 2 | Consumer Discretionary | 16.05% |
| 3 | Technology | 13.06% |
| 4 | Communication Services | 12.46% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Paycom
PAYC
$12.6B
| $15.7M | 0.01% |
458,643
+15,702
| +4% | +$536K |
|
|
BLOX
477
DELISTED
Infoblox Inc
BLOX
| $15.6M | 0.01% |
+593,719
| New | +$15.6M |
|
|
AVDL
478
Avadel Pharmaceuticals
AVDL
$1.5B
| $15.3M | 0.01% |
720,960
+7,190
| +1% | +$152K |
|
479
Treehouse Foods
THS
$891M
| $15.1M | 0.01% |
185,933
-326,352
| -64% | -$26.4M |
|
|
EPRS
480
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $15M | 0.01% |
2,630,942
+15,948
| +0.6% | +$91.1K |
|
|
TSRO
481
DELISTED
TESARO, Inc.
TSRO
| $14.9M | 0.01% |
252,674
+2,427
| +1% | +$143K |
|
|
KIN
482
DELISTED
Kindred Biosciences, Inc.
KIN
| $14.7M | 0.01% |
2,162,167
+14,985
| +0.7% | +$102K |
|
483
Madrigal Pharmaceuticals
MDGL
$10.1B
| $14.7M | 0.01% |
188,139
+1,363
| +0.7% | +$106K |
|
|
FEIC
484
DELISTED
FEI COMPANY
FEIC
| $14.7M | 0.01% |
177,023
+5,716
| +3% | +$474K |
|
|
DTEA
485
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $14.5M | 0.01% |
+673,864
| New | +$14.5M |
|
|
MPG
486
DELISTED
Metaldyne Performance Group Inc.
MPG
| $14.1M | 0.01% |
775,647
+4,059
| +0.5% | +$73.7K |
|
|
FCSC
487
DELISTED
Fibrocell Science Inc.
FCSC
| $14M | 0.01% |
177,002
+1,154
| +0.7% | +$91.2K |
|
|
INXN
488
DELISTED
Interxion Holding N.V.
INXN
| $13.8M | 0.01% |
500,753
-60,649
| -11% | -$1.68M |
|
|
NXTM
489
DELISTED
NxStage Medical Inc.
NXTM
| $13.4M | 0.01% |
936,988
+360,316
| +62% | +$5.15M |
|
|
CSII
490
DELISTED
Cardiovascular Systems, Inc.
CSII
| $12.5M | 0.01% |
472,831
-175,459
| -27% | -$4.64M |
|
491
Salarius Pharmaceuticals
SLRX
$2.4M
| $12.4M | 0.01% |
10
| – | – |
|
492
Targa Resources
TRGP
$34.3B
| $12M | 0.01% |
134,780
-435,963
| -76% | -$38.9M |
|
|
TUES
493
DELISTED
Tuesday Morning Corp
TUES
| $12M | 0.01% |
1,061,197
-33,274
| -3% | -$375K |
|
|
FENX
494
DELISTED
Fenix Parts, Inc.
FENX
| $11.8M | 0.01% |
+1,181,821
| New | +$11.8M |
|
495
Douglas Emmett
DEI
$2.75B
| $11.7M | 0.01% |
433,333
-5,505
| -1% | -$148K |
|
|
BKI
496
DELISTED
Black Knight, Inc. Common Stock
BKI
| $11.6M | 0.01% |
+376,020
| New | +$11.6M |
|
497
Owens Corning
OC
$13B
| $11.5M | 0.01% |
+277,909
| New | +$11.5M |
|
|
ROIC
498
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $11.1M | 0.01% |
710,502
+425,283
| +149% | +$6.64M |
|
|
WBC
499
DELISTED
WABCO HOLDINGS INC.
WBC
| $10.9M | 0.01% |
88,409
+2,722
| +3% | +$337K |
|
500
Sarepta Therapeutics
SRPT
$1.89B
| $10.7M | 0.01% |
+353,000
| New | +$10.7M |
|